Approved
By Alex Kesin and Matthew Pech
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Alex Kesin and Matthew Pech
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 8
Reviews: 0
Episodes: 6
Description
Life sciences, under the hood. Deep dives into the patent filings, regulatory gauntlets, and capital-risks that shape the business of biology.
| Episode | Date |
|---|---|
|
Allergan: Botox, Rogue Scientists, and the Ultimate Beauty Franchise
|
Sep 18, 2026 |
|
What is Approved?
|
Sep 14, 2026 |
|
Blueprint Medicines: Chasing Gleevec to a $9B Allergy Drug
|
Aug 04, 2026 |
|
Keytruda: How Merck's Pembrolizumab Became the Best-Selling Cancer Drug of All Time
|
May 14, 2026 |
|
Episode #2: Geron
|
Mar 13, 2026 |
|
Episode #1: Amylin Pharmaceuticals
|
Jan 30, 2026 |